Wabash Announces Second Quarter 2024 Results
Quarterly revenue of $551 million; within prior quarterly outlook range Operating income of $44 million with operating margin of 7.9% […]
Asensus Surgical Announces The Rocky Mountain Hospital for Children in Denver, Colorado to Initiate Senhance Surgery Program
RESEARCH TRIANGLE PARK, N.C., July 24, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of […]
Endeavour Silver provides a Q2 2024 construction progress update on Terronera; the surface construction progress has reached 77% completion
VANCOUVER, British Columbia, July 24, 2024 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (“Endeavour” or the “Company”) (NYSE: EXK; TSX: EDR) […]
TSX News -
Media Advisory: Hut 8 Announces Conference Call to Discuss Second Quarter 2024 Results
Miami, FL, July 24, 2024 (GLOBE NEWSWIRE) — Media Advisory: Hut 8 Announces Conference Call to Discuss Second Quarter 2024 […]
Parsons Corporation: Poised to Deliver Global Events Infrastructure on Demand
CHANTILLY, Va., July 24, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN), a leader in infrastructure, defense, security, transportation, and […]
Teleflex Announces the Teleflex Center for Antimicrobial Protection
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today […]
Planet 13 Announces Launch of New Lifestyles Brand Company with signing of first Sponsored Athlete, UFC Title Contender Chito Vera
LAS VEGAS, July 24, 2024 (GLOBE NEWSWIRE) — Planet 13 Holdings Inc. (CSE: PLTH) (OTCQX: PLNH) (“Planet 13” or the […]
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
Boston (July 24, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to […]
Skye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” and Details Phase 2 Nimacimab Clinical Trial Design Including Obstructive Sleep Apnea Exploratory Endpoints
SAN DIEGO, July 24, 2024 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biopharmaceutical company focused on […]
Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus Erythematosus
SOUTH SAN FRANCISCO, Calif., July 24, 2024 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural […]
